A Phase 2b, randomized,controlled, open-label study to evaluate the immune response and safety of the RSVPreF3 OA investigational vaccine inadults (?50years of age) when administered to lung and renal transplant recipients comparing 1 versus 2 doses an

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences